Cellectar Biosciences Executive Team Flushes New Options, Signaling Optimistic Outlook Amid Volatile Stock Price Flash.
Insider option grants at Cellectar Biosciences signal executive confidence and a bullish outlook for the drug‑development biotech, despite a volatile stock.
3 minutes to read